Skip to main content
Erschienen in: Journal of Genetic Counseling 6/2012

01.12.2012

Genetic Counseling, Activism and ‘Genotype-First’ Diagnosis of Developmental Disorders

verfasst von: Daniel Navon

Erschienen in: Journal of Genetic Counseling | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

This paper presents a sociological examination of the role of genetic counselors as advocates, not only for patients and their families, but also for genetic conditions themselves. In becoming activists for new disorders, genetic counselors are helping to create new categories that will shape expectations and treatment regimens for both existing patients and those who are yet to be diagnosed. By virtue of their expertise and their position at the intersection of several key professions and constituencies, genetic counselors are likely to play a central role in the way the genetic testing technologies, and especially ‘genotype-first’ diagnosis, impacts the way we understand and categorize developmental difference. I outline some of the promises and dangers that this kind of activism holds for people with developmental disabilities, and particularly the challenge presented by systemic ascertainment bias in the face of genotype-phenotype uncertainty. I argue that new testing techniques like microarray analysis that do not need to be targeted on the basis of clinical presentation throw these challenges into sharp relief, and that the genetic counseling community should consider how to marry advocacy for new genetic conditions with an emphasis on the indeterminate developmental potential of every child.
Literatur
Zurück zum Zitat Aronowitz, R. A. (1999). Making sense of illness: Science, society and disease. Cambridge University Press. Aronowitz, R. A. (1999). Making sense of illness: Science, society and disease. Cambridge University Press.
Zurück zum Zitat Bassett, A. S., McDonald-McGinn, D. M., Devriendt, K., Digilio, M. C., Goldenberg, P., Habel, A., et al. (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. The Journal of Pediatrics, 159(2), 332.e1–339.e1.CrossRef Bassett, A. S., McDonald-McGinn, D. M., Devriendt, K., Digilio, M. C., Goldenberg, P., Habel, A., et al. (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. The Journal of Pediatrics, 159(2), 332.e1–339.e1.CrossRef
Zurück zum Zitat Beckwith, J. (1972). Science for the people. Annals of the New York Academy of Sciences, 196(4), 236–240.PubMedCrossRef Beckwith, J. (1972). Science for the people. Annals of the New York Academy of Sciences, 196(4), 236–240.PubMedCrossRef
Zurück zum Zitat Bosk, C. L. (1992). All God’s mistakes: Genetic counseling in a pediatric hospital (1st ed.). University Of Chicago Press. Bosk, C. L. (1992). All God’s mistakes: Genetic counseling in a pediatric hospital (1st ed.). University Of Chicago Press.
Zurück zum Zitat Bretelle, F., Beyer, L., Pellissier, M. C., Missirian, C., Sigaudy, S., Gamerre, M., et al. (2010). Prenatal and postnatal diagnosis of 22q11.2 deletion syndrome. European Journal of Medical Genetics, 53(6), 367–370.PubMedCrossRef Bretelle, F., Beyer, L., Pellissier, M. C., Missirian, C., Sigaudy, S., Gamerre, M., et al. (2010). Prenatal and postnatal diagnosis of 22q11.2 deletion syndrome. European Journal of Medical Genetics, 53(6), 367–370.PubMedCrossRef
Zurück zum Zitat Brown, A., Phelan, M. C., Patil, S., Crawford, E., Rogers, R. C., & Schwartz, C. (1996). Two patients with duplication of 17p11.2: The reciprocal of the Smith-Magenis syndrome deletion? American Journal of Medical Genetics, 63(2), 373–377.PubMedCrossRef Brown, A., Phelan, M. C., Patil, S., Crawford, E., Rogers, R. C., & Schwartz, C. (1996). Two patients with duplication of 17p11.2: The reciprocal of the Smith-Magenis syndrome deletion? American Journal of Medical Genetics, 63(2), 373–377.PubMedCrossRef
Zurück zum Zitat Costain, G., Chow, E. W. C., Ray, P. N., & Bassett, A. S. (2012). Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. Journal of Intellectual Disability Research. Costain, G., Chow, E. W. C., Ray, P. N., & Bassett, A. S. (2012). Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. Journal of Intellectual Disability Research.
Zurück zum Zitat Deak, K. L., Horn, S. R., & Rehder, C. W. (2011). The evolving picture of microdeletion/microduplication syndromes in the age of microarray analysis: Variable expressivity and genomic complexity. Clinics in Laboratory Medicine, 31(4), 543–564.PubMedCrossRef Deak, K. L., Horn, S. R., & Rehder, C. W. (2011). The evolving picture of microdeletion/microduplication syndromes in the age of microarray analysis: Variable expressivity and genomic complexity. Clinics in Laboratory Medicine, 31(4), 543–564.PubMedCrossRef
Zurück zum Zitat Driscoll, D. A., Spinner, N. B., Budarf, M. L., McDonald-McGinn, D. M., Zackai, E. H., Goldberg, R. B., et al. (1992). Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. American Journal of Medical Genetics, 44(2), 261–268.PubMedCrossRef Driscoll, D. A., Spinner, N. B., Budarf, M. L., McDonald-McGinn, D. M., Zackai, E. H., Goldberg, R. B., et al. (1992). Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. American Journal of Medical Genetics, 44(2), 261–268.PubMedCrossRef
Zurück zum Zitat Finucane, B. (2011). 2012 National society of genetic counselors presidential address: Maintaining our professional identity in an ever-expanding genetics universe. Journal of Genetic Counseling, 21(1), 3–6.PubMedCrossRef Finucane, B. (2011). 2012 National society of genetic counselors presidential address: Maintaining our professional identity in an ever-expanding genetics universe. Journal of Genetic Counseling, 21(1), 3–6.PubMedCrossRef
Zurück zum Zitat Finucane, B., Haas-Givler, B., & Simon, E. W. (2003). Genetics, mental retardation, and the forging of new alliances. American Journal of Medical Genetics, 117C(1), 66–72.PubMedCrossRef Finucane, B., Haas-Givler, B., & Simon, E. W. (2003). Genetics, mental retardation, and the forging of new alliances. American Journal of Medical Genetics, 117C(1), 66–72.PubMedCrossRef
Zurück zum Zitat Greenberg, F., Lewis, R. A., Potocki, L., Glaze, D., Parke, J., Killian, J., et al. (1996). Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). American Journal of Medical Genetics, 62(3), 247–254.PubMedCrossRef Greenberg, F., Lewis, R. A., Potocki, L., Glaze, D., Parke, J., Killian, J., et al. (1996). Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). American Journal of Medical Genetics, 62(3), 247–254.PubMedCrossRef
Zurück zum Zitat Gropman, A. L., Duncan, W. C., & Smith, A. C. M. (2006). Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatric Neurology, 34(5), 337–350.PubMedCrossRef Gropman, A. L., Duncan, W. C., & Smith, A. C. M. (2006). Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatric Neurology, 34(5), 337–350.PubMedCrossRef
Zurück zum Zitat Heath, D., Rapp, R., & Taussig, K. (2004). Genetic citizenship. A Companion to the anthropology of politics. Blackwell. Heath, D., Rapp, R., & Taussig, K. (2004). Genetic citizenship. A Companion to the anthropology of politics. Blackwell.
Zurück zum Zitat Jacobs, P. A., Brunton, M., Melville, M. M., Brittain, R. P., & Mcclemont, W. F. (1965). Aggressive behaviour, mental sub-normality and the XYY male. Nature, 208(5017), 1351–1352.PubMedCrossRef Jacobs, P. A., Brunton, M., Melville, M. M., Brittain, R. P., & Mcclemont, W. F. (1965). Aggressive behaviour, mental sub-normality and the XYY male. Nature, 208(5017), 1351–1352.PubMedCrossRef
Zurück zum Zitat Larson, R. S., & Butler, M. G. (1995). Use of fluorescence in situ hybridization (FISH) in the diagnosis of DiGeorge sequence and related diseases. Diagnostic Molecular Pathology: The American Journal of Surgical Pathology, Part B, 4(4), 274–278.CrossRef Larson, R. S., & Butler, M. G. (1995). Use of fluorescence in situ hybridization (FISH) in the diagnosis of DiGeorge sequence and related diseases. Diagnostic Molecular Pathology: The American Journal of Surgical Pathology, Part B, 4(4), 274–278.CrossRef
Zurück zum Zitat Ledbetter, D. H. (2008). Cytogenetic technology – genotype and phenotype. New England Journal of Medicine, 359(16), 1728–1730.PubMedCrossRef Ledbetter, D. H. (2008). Cytogenetic technology – genotype and phenotype. New England Journal of Medicine, 359(16), 1728–1730.PubMedCrossRef
Zurück zum Zitat Lippmann, A. (1991). The geneticization of health and illness: Implications for social practice. Endocrinologie, 29(1–2), 85–90.PubMed Lippmann, A. (1991). The geneticization of health and illness: Implications for social practice. Endocrinologie, 29(1–2), 85–90.PubMed
Zurück zum Zitat McDonald-McGinn, D. M., & Zackai, E. H. (2008). Genetic counseling for the 22q11.2 deletion. Development Diabilities Research Reviews, 14(1), 69–74.CrossRef McDonald-McGinn, D. M., & Zackai, E. H. (2008). Genetic counseling for the 22q11.2 deletion. Development Diabilities Research Reviews, 14(1), 69–74.CrossRef
Zurück zum Zitat McDonald-McGinn, D. M., Zackai, E. H., & Low, D. (1997). What’s in a name? The 22q11.2 deletion. American Journal of Medical Genetics, 72(2), 247–249.PubMedCrossRef McDonald-McGinn, D. M., Zackai, E. H., & Low, D. (1997). What’s in a name? The 22q11.2 deletion. American Journal of Medical Genetics, 72(2), 247–249.PubMedCrossRef
Zurück zum Zitat McDonald-McGinn, D. M., Kirschner, R., Goldmuntz, E., Sullivan, K., Eicher, P., Gerdes, M., et al. (1999). The Philadelphia story: The 22q11.2 deletion: report on 250 patients. Genetic Counseling (Geneva, Switzerland), 10(1), 11–24. McDonald-McGinn, D. M., Kirschner, R., Goldmuntz, E., Sullivan, K., Eicher, P., Gerdes, M., et al. (1999). The Philadelphia story: The 22q11.2 deletion: report on 250 patients. Genetic Counseling (Geneva, Switzerland), 10(1), 11–24.
Zurück zum Zitat McDonald-McGinn, D. M., Tonnesen, M. K., Laufer-Cahana, A., Finucane, B., Driscoll, D. A., Emanuel, B. S., et al. (2001). Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net! Genetics in Medicine: Official Journal of the American College of Medical Genetics, 3, 23–29.CrossRef McDonald-McGinn, D. M., Tonnesen, M. K., Laufer-Cahana, A., Finucane, B., Driscoll, D. A., Emanuel, B. S., et al. (2001). Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net! Genetics in Medicine: Official Journal of the American College of Medical Genetics, 3, 23–29.CrossRef
Zurück zum Zitat Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies, 86(5), 749–764. Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies, 86(5), 749–764.
Zurück zum Zitat Navon, D. (2011). Genomic designation: How genetics can delineate new, phenotypically diffuse medical categories. Social Studies of Science, 41(2), 203–226.PubMedCrossRef Navon, D. (2011). Genomic designation: How genetics can delineate new, phenotypically diffuse medical categories. Social Studies of Science, 41(2), 203–226.PubMedCrossRef
Zurück zum Zitat Phelan, M. C. (2011). Interview, March 4th 2011, New York NY. Phelan, M. C. (2011). Interview, March 4th 2011, New York NY.
Zurück zum Zitat Phelan, M. C., Rogers, R. C., & Stevenson, R. E. (1988). A de novo terminal deletion of 22q. American Journal Of Human Genetics, 43, A118. Phelan, M. C., Rogers, R. C., & Stevenson, R. E. (1988). A de novo terminal deletion of 22q. American Journal Of Human Genetics, 43, A118.
Zurück zum Zitat Phelan, M. C., Rogers, R. C., Saul, R. A., Stapleton, G. A., Sweet, K., McDermid, H., et al. (2001). 22q13 deletion syndrome. American Journal of Medical Genetics, 101(2), 91–99.PubMedCrossRef Phelan, M. C., Rogers, R. C., Saul, R. A., Stapleton, G. A., Sweet, K., McDermid, H., et al. (2001). 22q13 deletion syndrome. American Journal of Medical Genetics, 101(2), 91–99.PubMedCrossRef
Zurück zum Zitat Potocki, L., Bi, W., Treadwell-Deering, D., Carvalho, C. M. B., Eifert, A., Friedman, E. M., et al. (2007). Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. American Journal of Human Genetics, 80(4), 633–649.PubMedCrossRef Potocki, L., Bi, W., Treadwell-Deering, D., Carvalho, C. M. B., Eifert, A., Friedman, E. M., et al. (2007). Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. American Journal of Human Genetics, 80(4), 633–649.PubMedCrossRef
Zurück zum Zitat Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Estabrooks Hahn, S., Strecker, M. N., et al. (2006). A new definition of genetic counseling: National society of genetic counselors’ task force report. Journal of Genetic Counseling, 15(2), 77–83.PubMedCrossRef Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Estabrooks Hahn, S., Strecker, M. N., et al. (2006). A new definition of genetic counseling: National society of genetic counselors’ task force report. Journal of Genetic Counseling, 15(2), 77–83.PubMedCrossRef
Zurück zum Zitat Shaffer, L. G., Bejjani, B. A., Torchia, B., Kirkpatrick, S., Coppinger, J., & Ballif, B. C. (2007). The identification of microdeletion syndromes and other chromosome abnormalities: Cytogenetic methods of the past, new technologies for the future. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 145C(4), 335–345.CrossRef Shaffer, L. G., Bejjani, B. A., Torchia, B., Kirkpatrick, S., Coppinger, J., & Ballif, B. C. (2007). The identification of microdeletion syndromes and other chromosome abnormalities: Cytogenetic methods of the past, new technologies for the future. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 145C(4), 335–345.CrossRef
Zurück zum Zitat Shaffer, L. G., Coppinger, J., Morton, S. A., Alliman, S., Burleson, J., Traylor, R., et al. (2011). The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes. Prenatal Diagnosis, 31(8), 778–787.PubMedCrossRef Shaffer, L. G., Coppinger, J., Morton, S. A., Alliman, S., Burleson, J., Traylor, R., et al. (2011). The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes. Prenatal Diagnosis, 31(8), 778–787.PubMedCrossRef
Zurück zum Zitat Smith, A. C., Dykens, E., & Greenberg, F. (1998). Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2. American Journal of Medical Genetics, 81(2), 179–185.PubMedCrossRef Smith, A. C., Dykens, E., & Greenberg, F. (1998). Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2. American Journal of Medical Genetics, 81(2), 179–185.PubMedCrossRef
Zurück zum Zitat Smith, A. C. M., Gropman, A. L., Bailey-Wilson, J. E., Goker-Alpan, O., Elsea, S. H., Blancato, J., Lupski, J. R., et al. (2002). Hypercholesterolemia in children with Smith-Magenis syndrome: del (17) (p11.2p11.2). Genetics in Medicine: Official Journal of the American College of Medical Genetics, 4(3), 118–125.CrossRef Smith, A. C. M., Gropman, A. L., Bailey-Wilson, J. E., Goker-Alpan, O., Elsea, S. H., Blancato, J., Lupski, J. R., et al. (2002). Hypercholesterolemia in children with Smith-Magenis syndrome: del (17) (p11.2p11.2). Genetics in Medicine: Official Journal of the American College of Medical Genetics, 4(3), 118–125.CrossRef
Zurück zum Zitat Terry, S. F., Terry, P. F., Rauen, K. A., Uitto, J., & Bercovitch, L. G. (2007). Advocacy groups as research organizations: The PXE International example. Nature Reviews Genetics, 8(2), 157–164.PubMedCrossRef Terry, S. F., Terry, P. F., Rauen, K. A., Uitto, J., & Bercovitch, L. G. (2007). Advocacy groups as research organizations: The PXE International example. Nature Reviews Genetics, 8(2), 157–164.PubMedCrossRef
Zurück zum Zitat Veltman, J. A., & Brunner, H. G. (2010). Understanding variable expressivity in microdeletion syndromes. Nature Genetics, 42(3), 192–193.PubMedCrossRef Veltman, J. A., & Brunner, H. G. (2010). Understanding variable expressivity in microdeletion syndromes. Nature Genetics, 42(3), 192–193.PubMedCrossRef
Zurück zum Zitat Verkerk, A., Pieretti, M., Sutcliffe, J., Fu, Y., Kuhl, D., Pizzuti, A., et al. (1991). Identification of A Gene (Fmr-1) containing A Cgg Repeat coincident with a breakpoint cluster region exhibiting length variation in fragile-X syndrome. Cell, 65(5), 905–914.PubMedCrossRef Verkerk, A., Pieretti, M., Sutcliffe, J., Fu, Y., Kuhl, D., Pizzuti, A., et al. (1991). Identification of A Gene (Fmr-1) containing A Cgg Repeat coincident with a breakpoint cluster region exhibiting length variation in fragile-X syndrome. Cell, 65(5), 905–914.PubMedCrossRef
Zurück zum Zitat Whitmarsh, I., Davis, A. M., Skinner, D., & Bailey, D. B. (2007). A place for genetic uncertainty: Parents valuing an unknown in the meaning of disease. Social Science & Medicine, 65(6), 1082–1093.CrossRef Whitmarsh, I., Davis, A. M., Skinner, D., & Bailey, D. B. (2007). A place for genetic uncertainty: Parents valuing an unknown in the meaning of disease. Social Science & Medicine, 65(6), 1082–1093.CrossRef
Metadaten
Titel
Genetic Counseling, Activism and ‘Genotype-First’ Diagnosis of Developmental Disorders
verfasst von
Daniel Navon
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 6/2012
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-012-9515-9

Weitere Artikel der Ausgabe 6/2012

Journal of Genetic Counseling 6/2012 Zur Ausgabe

Professional Issues

Full-Spectrum Parenting

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.